This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Khair K. The changing role of the specialist haemophilia nurse. Nursing Times [online] 2021; 117(9): 50-52. Available from https://www.nursingtimes.net/clinical-archive/haematology/the-changing-role-of-the-specialist-haemophilia-nurse-09-08-2021/ (accessed 31 March 2023).KhairK.The changing role of the specialist haemophilia nurse.2021;117(9):50-52.Available from https://www.nursingtimes.net/clinical-archive/haematology/the-changing-role-of-the-specialist-haemophilia-nurse-09-08-2021/(accessed 31 March 2023).Search in Google Scholar
Oldenburg J, Mahlangu JM, Kim B, et al. Emicizumab prophylaxis in haemophilia A with inhibitors. N Eng J Med 2017; 377: 809-818. doi: 10.1056/NEJMoa1703068.OldenburgJMahlanguJMKimB.Emicizumab prophylaxis in haemophilia A with inhibitors.2017;377:809-818. doi:10.1056/NEJMoa1703068.Open DOISearch in Google Scholar
Rodríguez-Merchán EC, Valentino LA. Emicizumab: Review of the literature and critical appraisal. Haemophilia 2019; 25(1): 11-20. doi: 10.1111/hae.13641.Rodríguez-MerchánECValentinoLA.Emicizumab: Review of the literature and critical appraisal.2019;25(1):11-20. doi:10.1111/hae.13641.Open DOISearch in Google Scholar
Jiménez-Yuste V, Rodríguez-Merchán EC, Matsushita T, Holme PA. Concomitant use of bypassing agents for people with haemophilia A and inhibitors undergoing surgery. Haemophilia 2021; 27(4): 519-530. doi: 10.1111/hae.14322.Jiménez-YusteVRodríguez-MerchánECMatsushitaTHolmePA.Concomitant use of bypassing agents for people with haemophilia A and inhibitors undergoing surgery.2021;27(4):519-530. doi:10.1111/hae.14322.Open DOISearch in Google Scholar
Linari S, Castaman G. Concomitant use of rVIIa and emicizumab in people with hemophilia A with inhibitors: current perspectives and emerging clinical evidence. Ther Clin Risk Manad 2020; 16: 461-469. doi: 10.2147/TCRM.S205310.LinariSCastamanG.Concomitant use of rVIIa and emicizumab in people with hemophilia A with inhibitors: current perspectives and emerging clinical evidence.2020;16:461-469. doi:10.2147/TCRM.S205310.Open DOISearch in Google Scholar